(Q37180356)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

0 references

0 references

José Luis Pérez-Gracia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jackeline Agorreta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Juan P de Torres

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Eloisa Jantus Lewintre

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Carlos Camps

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Javier J. Zulueta

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Ruben Pio

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Daniel Ajona

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

María J Pajares

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Leticia Corrales

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Maria D Lozano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Wenceslao Torre

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Pierre P Massion

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Luis M Montuenga

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

language of work or name

English

0 references

publication date

12 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Cancer Institute

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

1385-1393

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

cites work

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

The state of molecular biomarkers for the early detection of lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Pros and cons for C4d as a biomarker

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Immunotherapy for non-small cell lung cancer: novel approaches to improve patient outcome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Reduced lung-cancer mortality with low-dose computed tomographic screening

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Cancer and the complement cascade

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Complement: a key system for immune surveillance and homeostasis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

New insights into the molecular mechanisms of classical complement activation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Modulation of the antitumor immune response by complement

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

C1q and its growing family.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Differential exoprotease activities confer tumor-specific serum peptidome patterns

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Specific inhibition of the classical complement pathway by C1q-binding peptides.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Revisions in the International System for Staging Lung Cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Immunoglobulins and complement in pleural effusions associated with bronchogenic carcinoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Expression and distribution of cell-membrane complement regulatory glycoproteins along the human respiratory tract

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistanc

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776260

Immune response as a biomarker for cancer detection and a lot more

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23940286

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Combined VEGF-A and VEGFR-2 concentrations in plasma: Diagnostic and prognostic implications in patients with advanced NSCLC

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23940286

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Immunoglobulins and complement components levels in patients with lung cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23940286

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JNCI/DJT205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

PubMed publication ID

23940286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23940286%20AND%20SRC:MED&resulttype=core&format=json